Speaker

Steffen-Sebastian Bolz

Executive Board Member and Chief Scientific Officer, APHAIA Pharma AG

Steffen-Sebastian Bolz, Executive Board Member and Chief Scientific Officer, APHAIA Pharma AG, is speaking at 2nd Obesity & Weight Loss Drug Development Summit Europe (Munich, Germany, 28–29 Oct 2026) in the session “Panel Discussion: Evaluating Opportunities to Improve Long-Term Weight Loss Management”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Upcoming appearances

2nd Obesity & Weight Loss Drug Development Summit Europe
28–29 Oct 2026Munich, Germany
- PanelPanel Discussion: Evaluating Opportunities to Improve Long-Term Weight Loss ManagementWith Xavier Jacq, Brent Meadows
- SpeakerIntegrating L Cell Sensing & Neural Afferent Signalling to Enable Long- Term Metabolic Stability

More speakers at 2nd Obesity & Weight Loss Drug Development Summit Europe

Anna Altieri
Translational Research Associate, Resalis Therapeutics
Henrik Bjork Hansen
Director - Scientific, Gubra
Martin Brenner
Chief Executive & Scientific Officer, iBio
Daniel de la Torre
VP of Research & Development, Constructive Bio
Mélanie Flaender
Head of Project Management, Cytoo
Lora Heisler
Professor, University of Aberdeen

See all 17 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Steffen-Sebastian Bolz, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].